$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
服用芦可替尼治疗期间需要注意的事项有什么?
2025-10-19 11:44:20
Check Details
骨髓纤维化治疗用药鲁可替尼安全性怎么样?
2025-10-19 11:44:20
Check Details
骨髓纤维化药物鲁索替尼哪里有?
2025-10-19 11:44:20
Check Details
骨髓纤维化患者用鲁可替尼治疗的效果
2025-10-19 11:44:20
Check Details
原发性骨髓纤维化治疗新药-鲁可替尼
2025-10-19 11:44:20
Check Details
鲁可替尼(鲁索替尼)服用注意事项
2025-10-19 11:44:20
Check Details
治疗高危骨髓纤维化药物鲁可替尼去哪买的到?
2025-10-19 11:44:20
Check Details
骨髓纤维化药物鲁可替尼吃多久可以停药?
2025-10-19 11:44:20
Check Details
鲁可替尼(鲁索替尼)在医保范围内吗?
2025-10-19 11:44:20
Check Details
鲁索利替尼能治好骨髓纤维化吗?
2025-10-19 11:44:20
Check Details
骨髓纤维化药物鲁索利替尼哪里买?
2025-10-19 11:44:20
Check Details
鲁索利替尼(芦可替尼)服用方法
2025-10-19 11:44:20
Check Details
1
2
...
4405
4406
4407
4408
4409
4410
4411
...
10231
10232
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Bedaquiline Drug Interactions: CYP3A4 and QT Prolongation Risks
2
Acalabrutinib Dosing Guide: Dosage, Duration and Precautions
3
Epclusa (Sofosbuvir/Velpatasvir) Pan-Genotypic HCV Treatment: Mechanism, Efficacy, and Dosing
4
Laos Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) Generic Guide: Efficacy, Regimen Selection, and Precautions
5
Finerenone: Indications, Dosing Strategy, and Combination Therapy
6
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
7
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
8
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
9
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
10
Erdafitinib Oral Tablets: Strengths, Packaging, and Dose Adjustment
11
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
12
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC